Reckitt Benckiser, Inc., First Quarter 2009 Results
April 28, 2009 This is a report on first quarter 2009 results from Reckitt Benckiser, which markets Suboxone and Subutex, formulations of buprenorphine, through its pharmaceuticals division. The two medications are used for outpatient treatment of opioid addiction. The medications will lose patent protection in October 2009. This report discusses Reckitt Benckiser's plans. Download the Report . . .
